Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Author(s) -
James D. Douketis,
Alex C. Spyropoulos,
Scott Kaatz,
Richard C. Becker,
Joseph A. Caprini,
Andrew Dunn,
David García,
Alan K. Jacobson,
Amir K. Jaffer,
David F. Kong,
Sam Schulman,
Alexander G.G. Turpie,
Vic Hasselblad,
Thomas L. Ortel
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1501035
Subject(s) - medicine , perioperative , bridging (networking) , warfarin , atrial fibrillation , anesthesia , low molecular weight heparin , placebo , surgery , randomized controlled trial , anticoagulant , heparin , cardiology , computer network , alternative medicine , pathology , computer science
It is uncertain whether bridging anticoagulation is necessary for patients with atrial fibrillation who need an interruption in warfarin treatment for an elective operation or other elective invasive procedure. We hypothesized that forgoing bridging anticoagulation would be noninferior to bridging with low-molecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be superior to bridging with respect to major bleeding.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom